Article
Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma.
Nature communications - 5 Nov 2025
Sharma Sunandini, Ali Roshia, Bouska Alyssa, Jochum Dylan, Kesireddy Meghana, Mahov Simeon, Lownik Joseph, Zhang Weiwei, Lone Waseem, Soma Mahfuza Afroz, Gamboa Alicia, Devarakonda Vaishnavi, El-Gamal Dalia, Fariha Atqiya, Mansoor Adnan, Stewart Douglas, Martin Peter, Link Brian K, Advani Ranjana H, Barr Paul M, Goy Andre H, Mehta Amitkumar, Kamdar Manali, Stephens Deborah M, Bachanova Veronika, Smith Lynette, Morin Ryan, Pararajalingam Prasath, Lunning Matthew A, Fu Kai, Weisenburger Dennis, Chan Wing C, Khoury Joseph, Greiner Timothy C, Vose Julie M, Merchant Akil, Bi Chengfeng, Iqbal Javeed
Abstract excerpt
Mantle cell lymphoma (MCL) is a genetically and clinically heterogeneous B-cell malignancy. We studied two MCL cohorts with differing treatment patterns: one enriched for immunochemotherapy, the other for chemotherapy alone. TP53 alterations are consistently associated with poor prognosis, whereas ATM mutations correlate with improved outcomes following rituximab-based chemotherapy. Based on recurrent genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
